Ophthalmic Medical Lasers Market Report 2026

Ophthalmic Medical Lasers Market Overview

• Ophthalmic Medical Lasers market size has reached to $1.33 billion in 2025 • Expected to grow to $1.89 billion in 2030 at a compound annual growth rate (CAGR) of 7.1% • Growth Driver: Elderly Population Growth Fuels Ophthalmic Medical Lasers Market Expansion • Market Trend: Advancements In Precision Technologies Driving Innovation In Ophthalmic Medical Lasers • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Ophthalmic Medical Lasers Market?

Ophthalmic medical lasers are used in the treatment of diseases related to the eye. These lasers offer precision and minimally invasive treatment options, enhancing patient outcomes and recovery times in various ophthalmic procedures. The main products of the ophthalmic medical lasers are diode lasers, femtosecond lasers, excimer lasers for aromatherapy, ND:YAG lasers, and others. A diode laser is a semiconductor that produces coherent radiation with the same frequency and phase, either in the visible or infrared spectrum, using a p-n junction. The various applications include refractive error correction, cataract removal, diabetic retinopathy, glaucoma, age-related macular degeneration, and others. The various end-users are hospitals, specialty clinics, and ambulatory surgery centers.

What Is The Ophthalmic Medical Lasers Market Growth Forecast?

The ophthalmic medical lasers market size is expected to see strong growth in the next few years. It will grow to $1.89 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to increasing demand for advanced vision correction solutions, rising investments in ophthalmic laser innovation, expansion of laser-assisted surgeries in emerging markets, growing focus on personalized eye treatments, increasing adoption of AI-assisted laser guidance. Major trends in the forecast period include increasing adoption of minimally invasive laser procedures, rising use of femtosecond lasers in cataract surgery, growing precision in refractive error correction, expansion of multi-wavelength laser platforms, enhanced focus on faster patient recovery.

Global Ophthalmic Medical Lasers Market Segmentation

1) By Product: Diode Lasers, Femtosecond Lasers, Excimer Lasers, Tissue Treatment Lasers, ND:Yag Lasers, Other Products 2) By Application: Refractive Error Correction, Cataract Removal, Diabetic Retinopathy, Glaucoma, Age-Related Macular Degeneration, Other Applications 3) By End User: Hospitals, Specialty Clinics and Ambulatory Surgery Centres Subsegments: 1) By Diode Lasers: Laser For Retinal Surgery, Laser For Cataract Surgery 2) By Femtosecond Lasers: Laser For Cataract Surgery, Laser For LASIK Surgery 3) By Excimer Lasers: Laser For Refractive Surgeries (LASIK, PRK), Laser For Corneal Surgery 4) By Tissue Treatment Lasers: Lasers For Photodynamic Therapy, Laser For Tissue Treatment 5) By ND:YAG Lasers: Laser For Posterior Capsulotomy, Laser For Iridotomy 6) By Other Products: Laser For Glaucoma Treatment, Laser For Retinal Photocoagulation

What Is The Driver Of The Ophthalmic Medical Lasers Market?

The increasing elderly population is expected to propel the growth of the ophthalmic medical lasers market going forward. The elderly population refers to the senior population of individuals aged 65 years and older. The increase in the elderly population is due to longer life expectancy and improved overall survival, resulting in a larger proportion of older adults within the population. Ophthalmic medical lasers are used for the elderly population to perform cataract surgery, glaucoma, age-related macular degeneration (AMD), diabetic retinopathy, refractive lens exchange, and other treatments. For instance, in October 2025, according to the World Health Organization, a Switzerland-based health organizationby 2030, 1 in 6 people globally (approximately 1.4 billion) will be aged 60 years or older. Additionally, by 2050, this number is projected to double, reaching 2.1 billion older adults worldwide.

Key Players In The Global Ophthalmic Medical Lasers Market

Major companies operating in the ophthalmic medical lasers market are Alcon Laboratories Inc., Abbott Medical Optics Inc., Carl Zeiss Meditec AG, Bausch & Lomb Incorporated, Topcon Corporation, Ziemer Ophthalmic Systems AG, IRIDEX Corporation, NIDEK Co. Ltd., Lumenis Ltd., Johnson & Johnson Surgical Vision Inc., Lumibird Medical, Quantel Inc., Coherent Inc., Ocular Instruments Inc., Ellex Medical Lasers Limited, LENSAR LLC, LIGHTMED Corporation, Menicon Co. Ltd., Novartis AG, Omeros Corporation, Oxurion NV, Regeneron Pharmaceuticals Inc., Roche Holding AG, Rohto Pharmaceutical Co. Ltd., Santen Pharmaceuticals, SCHWIND eye-tech-solutions GmbH & Co. KG, Staar Surgical Company, ThromboGenics NV

Global Ophthalmic Medical Lasers Market Trends and Insights

Major companies operating in the ophthalmic medical lasers market are focusing on developing innovative advancements, such as next-generation intraoperative radiotherapy (IORT) platforms, to enhance precision, workflow efficiency, and patient safety during cancer treatment procedures. Next-generation IORT platforms refer to advanced systems that deliver targeted radiation directly to the tumor site during surgery, minimizing exposure to surrounding healthy tissues while enabling more controlled and efficient treatment. For instance, in April 2025, ZEISS, a Germany-based medical technology company, received FDA 510(k) clearance for its INTRABEAM 700 system, a robotic-assisted IORT solution designed to provide highly focused radiation therapy for neuro-oncology and breast cancer surgeries. The platform features improved imaging integration, optimized ergonomics, and greater control during radiation delivery, supporting surgeons in achieving more accurate intraoperative treatment.

What Are Latest Mergers And Acquisitions In The Ophthalmic Medical Lasers Market?

In July 2024, Alcon, a Switzerland-based healthcare company acquired BELKIN Vision for an undisclosed amount. The aim of the acquisition is to expand Alcon’s glaucoma, enhancing access to first-line laser treatment for glaucoma patients globally. BELKIN Vision is an Israel-based medical technology company, focus on developing innovative laser treatments.

Regional Outlook

North America was the largest region in the ophthalmic medical lasers market in 2025. Asia-Pacific was the second-largest region in the ophthalmic medical lasers market report. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.

What Defines the Ophthalmic Medical Lasers Market?

The ophthalmic medical lasers market consists of sales of instruments such as SLT lasers, excimer lasers, cyclodiode lasers, and femtosecond lasers. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.